AbbVie Denies Overlapping Patents in Most Recent Adalimumab Litigation.
- Published in:
- Rheumatology, 2018, v. 57, n. 1, p. e47, doi. 10.1093/rheumatology/kex486
- Publication type:
- Article
Works matching IS 14620324 AND DT 2018 AND VI 57 AND IP 1
Results: 36
1
2
Biosimilars Forum Applauds Food and Drug Administration on New Educational Program Promoting Safety and Effectiveness of Biosimilars.
- Published in:
- Rheumatology, 2018, v. 57, n. 1, p. e46, doi. 10.1093/rheumatology/kex473
- Publication type:
- Article
3
Guidelines for the management of systemic lupus erythematosus: great synthesis of evidence and eminence with limited focus on patient's needs.
- Published in:
- 2018
- By:
- Publication type:
- Editorial
4
Serious infusion-related reaction after rituximab, abatacept and tocilizumab in rheumatoid arthritis: prospective registry data.
- Published in:
- Rheumatology, 2018, v. 57, n. 1, p. 134, doi. 10.1093/rheumatology/kex403
- By:
- Publication type:
- Article
5
Patient acceptable symptom state in scleroderma: results from the tocilizumab compared with placebo trial in active diffuse cutaneous systemic sclerosis.
- Published in:
- Rheumatology, 2018, v. 57, n. 1, p. 152, doi. 10.1093/rheumatology/kex396
- By:
- Publication type:
- Article
6
Autoantibodies to the survival of motor neuron complex in a patient with necrotizing autoimmune myopathy.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
7
Prevalence and predictors of tumour necrosis factor inhibitor persistence in psoriatic arthritis.
- Published in:
- Rheumatology, 2018, v. 57, n. 1, p. 158, doi. 10.1093/rheumatology/kex387
- By:
- Publication type:
- Article
8
Blockade of GM-CSF pathway induced sustained suppression of myeloid and T cell activities in rheumatoid arthritis.
- Published in:
- Rheumatology, 2018, v. 57, n. 1, p. 175, doi. 10.1093/rheumatology/kex383
- By:
- Publication type:
- Article
9
The effect of hydroxychloroquine on haemostasis, complement, inflammation and angiogenesis in patients with antiphospholipid antibodies.
- Published in:
- Rheumatology, 2018, v. 57, n. 1, p. 120, doi. 10.1093/rheumatology/kex378
- By:
- Publication type:
- Article
10
Familial Mediterranean fever mutations are hypermorphic mutations that specifically decrease the activation threshold of the Pyrin inflammasome.
- Published in:
- Rheumatology, 2018, v. 57, n. 1, p. 100, doi. 10.1093/rheumatology/kex373
- By:
- Publication type:
- Article
11
IgG4-related disease presenting with raised serum IgG2--real timeline of IgG4-RD?
- Published in:
- 2018
- By:
- Publication type:
- Case Study
12
Clinical trial parameters that influence outcomes in lupus trials that use the systemic lupus erythematosus responder index.
- Published in:
- Rheumatology, 2018, v. 57, n. 1, p. 125, doi. 10.1093/rheumatology/kex368
- By:
- Publication type:
- Article
13
Decreased incidence of gout in diabetic patients using pioglitazone.
- Published in:
- Rheumatology, 2018, v. 57, n. 1, p. 92, doi. 10.1093/rheumatology/kex363
- By:
- Publication type:
- Article
14
Work productivity in systemic sclerosis, its economic burden and association with health-related quality of life.
- Published in:
- Rheumatology, 2018, v. 57, n. 1, p. 73, doi. 10.1093/rheumatology/kex362
- By:
- Publication type:
- Article
15
Tapering versus steady-state methotrexate in combination with tocilizumab for rheumatoid arthritis: a randomized, double-blind trial.
- Published in:
- Rheumatology, 2018, v. 57, n. 1, p. 84, doi. 10.1093/rheumatology/kex358
- By:
- Publication type:
- Article
16
The proposed role of ultrasound in the management of giant cell arteritis in routine clinical practice.
- Published in:
- Rheumatology, 2018, v. 57, n. 1, p. 112, doi. 10.1093/rheumatology/kex341
- By:
- Publication type:
- Article
17
Interleukin-6 flags infection in tocilizumab-treated giant cell arteritis.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
18
Increased expression of interleukin-22 in patients with giant cell arteritis.
- Published in:
- Rheumatology, 2018, v. 57, n. 1, p. 64, doi. 10.1093/rheumatology/kex334
- By:
- Publication type:
- Article
19
Development of a national audit tool for juvenile idiopathic arthritis: a BSPAR project funded by the Health Care Quality Improvement Partnership.
- Published in:
- Rheumatology, 2018, v. 57, n. 1, p. 140, doi. 10.1093/rheumatology/kex322
- By:
- Publication type:
- Article
20
The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults: Executive Summary.
- Published in:
- Rheumatology, 2018, v. 57, n. 1, p. 14, doi. 10.1093/rheumatology/kex291
- By:
- Publication type:
- Article
21
The British Society for Rheumatology guideline for the management of systemic lupus erythematosus in adults.
- Published in:
- Rheumatology, 2018, v. 57, n. 1, p. e1, doi. 10.1093/rheumatology/kex286
- By:
- Publication type:
- Article
22
Toward cellular biomarkers for rheumatoid arthritis: Biomarkers in RA.
- Published in:
- 2018
- By:
- Publication type:
- Editorial
23
Pragmatic trials in osteoarthritis--Are we ready? Analysing delivery in clinical care.
- Published in:
- 2018
- By:
- Publication type:
- Editorial
24
Magnetic resonance imaging versus ultrasonography for the diagnosis of synovitis in rheumatoid arthritis: Comparing MRI and US for synovitis diagnosis.
- Published in:
- 2018
- By:
- Publication type:
- Editorial
25
Can epidemiological studies uncover the origin of Behçet's disease? The origin of Behçet's disease.
- Published in:
- 2018
- By:
- Publication type:
- Editorial
26
Musculoskeletal manifestations of Ebola virus.
- Published in:
- Rheumatology, 2018, v. 57, n. 1, p. 28, doi. 10.1093/rheumatology/kex082
- By:
- Publication type:
- Article
27
The problem in differentiation between psoriatic-related polyenthesitis and fibromyalgia.
- Published in:
- Rheumatology, 2018, v. 57, n. 1, p. 32, doi. 10.1093/rheumatology/kex079
- By:
- Publication type:
- Article
28
Chronic recurrent multifocal osteomyelitis in children and adults: current understanding and areas for development.
- Published in:
- Rheumatology, 2018, v. 57, n. 1, p. 41, doi. 10.1093/rheumatology/kex066
- By:
- Publication type:
- Article
29
Uncommon local reaction at the injection site of subcutaneous methotrexate.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
30
Rheumatological complications of beta-thalassaemia: an overview.
- Published in:
- Rheumatology, 2018, v. 57, n. 1, p. 19, doi. 10.1093/rheumatology/kex058
- By:
- Publication type:
- Article
31
Evaluating the design and reporting of pragmatic trials in osteoarthritis research.
- Published in:
- Rheumatology, 2018, v. 57, n. 1, p. 59, doi. 10.1093/rheumatology/kex050
- By:
- Publication type:
- Article
32
Diagnostic test accuracy of ultrasound for synovitis in rheumatoid arthritis: systematic review and meta-analysis.
- Published in:
- Rheumatology, 2018, v. 57, n. 1, p. 49, doi. 10.1093/rheumatology/kex036
- By:
- Publication type:
- Article
33
Central nervous system vasculitis presenting as an ischaemic stroke in a young woman with systemic sclerosis.
- Published in:
- 2018
- By:
- Publication type:
- Case Study
34
Differential effects of biological DMARDs on peripheral immune cell phenotypes in patients with rheumatoid arthritis.
- Published in:
- Rheumatology, 2018, v. 57, n. 1, p. 164, doi. 10.1093/rheumatology/kex012
- By:
- Publication type:
- Article
35
The funding lottery for potentially life-threatening rare diseases: It's not fair, my disease is rare.
- Published in:
- 2018
- By:
- Publication type:
- Editorial
36
Exploring the variability in Behçet's disease prevalence: a meta-analytical approach.
- Published in:
- Rheumatology, 2018, v. 57, n. 1, p. 185, doi. 10.1093/rheumatology/kew486
- By:
- Publication type:
- Article